Thyroid dysfunctions induced by molecular cancer therapies: a synopsis for nuclear medicine thyroidologists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thyroid dysfunctions induced by molecular cancer therapies: a synopsis for nuclear medicine thyroidologists

Published:2021-05-10 Issue:11 Volume:48 Page:3355-3360
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Petranović Ovčariček Petra,Deandreis Desiree,Giovanella Luca

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-021-05394-0.pdf

Reference19 articles.

1. Bhattacharya S, Goyal A, Kaur P, Singh R, Kalra S. anticancer drug-induced thyroid dysfunction. Eur Endocrinol. 2020 [cited 2020 Jun 29];16(1):32. Available from: https://www.touchendocrinology.com/anticancer-drug-induced-thyroid-dysfunction/.

2. Miyake H, Kurahashi T, Yamanaka K, Kondo Y, Muramaki M, Takenaka A, et al. Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation. Urol Oncol. 2010 [cited 2021 Apr 12];28(5):515–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19914105.

3. Eroukhmanoff J, Castinetti F, Penel N, Salas S. Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma. BMC Cancer. 2016 [cited 2020 Jul 7];16(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997685/.

4. Abdel-Rahman O, Fouad M. Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis. Expert Rev Anticancer Ther. 2014 Sep 13 [cited 2020 May 5];14(9):1063–73. Available from: http://www.tandfonline.com/doi/full/10.1586/14737140.2014.929501.

5. Byun DJ, Wolchok JD, Rosenberg LM, Girotra M. Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. 2017 Apr 20 [cited 2020 May 4];13(4):195–207. Available from: http://www.nature.com/articles/nrendo.2016.205.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular imaging of thyroid and parathyroid diseases;Expert Review of Endocrinology & Metabolism;2024-06-18

2. Autoimmune Thyroid Diseases;Seminars in Nuclear Medicine;2023-12

3. Integrated Thyroid Imaging: Ultrasound and Scintigraphy;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023

4. Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors;Medical Sciences;2022-11-21

5. The role of PET/CT in thyroid autoimmune diseases;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3